FindTrial
Sign In

SIGNIFICANCE OF IL-6 VALUE IN PATIENTS PRESENTING WITH SYSTEMIC INFLAMMATORY RESPONSE SYNDROME IN PREDICTING OUTCOME - AN OBSERVATIONAL STUDY

Prognostic value of IL-6 in SIRS- A Prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/084940
Enrollment
250
Registered
2025-04-16
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: NIL: NIL

Sponsors

PRS Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients admitted to our ICU who gave informed consent for the study meeting 1. SIRS criteria with suspected or confirmed sepsis and /or 2. Presenting in Shock

Exclusion criteria

Exclusion criteria: 1. Children less than 18 years of age 2. Patients on long term steroid therapy or immunosuppressive agents 3. Pregnant women 4. Diagnosed cases of congenital or acquired immunodeficiency

Design outcomes

Primary

MeasureTime frame
Mortality Timepoint: 28 days—

Secondary

MeasureTime frame
Comparison of IL-6 values to determine 1.Incidence or onset of organ dysfunction 2.Need for initiation of mechanical ventilation & its duration 3.Initiation of renal replacement therapy with or without hemofeel 4.Need for vasoactive agents or ECMO (Extra Corporeal Membrane Oxygenation) 5. Duration of ICU stay Timepoint: At the time of admission & 48 hourly till date of discharge from ICU—

Countries

India

Contacts

Public ContactDr Vivek P

PRS Hospital

drpvivek@hotmail.com9496206988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026